Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

4.41
Delayed Data
As of Feb 12
 +0.07 / +1.61%
Today’s Change
4.34
Today|||52-Week Range
11.28
-45.35%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close4.34
Today’s open4.44
Day’s range4.40 - 4.50
Volume25,361
Average volume (3 months)15,932
Market cap$47.2M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+23.95%
Earnings growth (this year)-3.42%
Earnings growth (next 5 years)--
Revenue growth (last year)+92.84%
P/E ratioNM
Price/Sales17.55
Price/Book6.82

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...+0.01+0.60%
VBIVVBI Vaccines Inc0.000.00%
ORPNBio Blast Pharma Ltd+0.14+4.91%
QUREUniqure NV+0.13+0.91%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 25, 2016
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$5.9M
Annual profit (last year)-$16.8M
Net profit margin-284.22%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Adam S. Grossman
Chief Financial Officer &
Vice President
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts

Partner Offers